Intraday Price Movement and Circuit Trigger
On the day in question, Venus Remedies' stock traded within a price band of ₹5, with the highest price recorded at ₹779.0 and the lowest at ₹732.5. The stock ultimately settled at ₹770.0, reflecting a decline of ₹1.05 or 0.14% from the previous close. This movement triggered the lower circuit, a mechanism designed to curb excessive volatility by halting further declines once a preset threshold is reached.
The lower circuit hit indicates that selling pressure overwhelmed buying interest, causing the stock to reach the maximum permissible loss for the day. Such a scenario often reflects heightened investor anxiety or reaction to market developments, leading to a sharp drop in price within a short span.
Trading Volumes and Liquidity Analysis
Trading volumes for Venus Remedies stood at approximately 0.35323 lakh shares, with a turnover of ₹2.67 crore. While the stock is classified as a micro-cap with a market capitalisation of ₹1,003 crore, liquidity remains adequate for moderate trade sizes, supported by a 2% threshold of the five-day average traded value, which equates to roughly ₹0.26 crore.
However, a notable decline in investor participation was observed, with delivery volumes on 3 December falling by 85.14% compared to the five-day average. This drop in delivery volume suggests a reduction in genuine buying interest, potentially exacerbating the downward price pressure.
Sector and Market Context
Venus Remedies' performance on the day was broadly in line with its sector, which recorded a marginal gain of 0.05%. In contrast, the broader Sensex index advanced by 0.41%, indicating that the stock's decline was somewhat isolated and not reflective of the overall market trend.
Despite the setback, Venus Remedies remains positioned close to its 52-week high, trading just 3.87% below the peak price of ₹799.8. The stock has been trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling underlying technical strength despite the recent dip.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
See This Week's Special Pick →
Investor Sentiment and Price Trend
The stock had experienced three consecutive days of gains prior to this decline, suggesting a recent positive momentum that was abruptly reversed. The fall on 4 December 2025 marks a trend reversal, with the lower circuit hit underscoring the intensity of selling pressure.
Such a sharp movement often reflects a combination of factors including profit booking, market rumours, or sector-specific developments. The lack of sufficient buyers to absorb the selling interest led to unfilled supply, pushing the stock to its daily loss limit.
Technical Indicators and Moving Averages
Despite the day's setback, Venus Remedies continues to trade above its short-term and long-term moving averages, which typically act as support levels. This positioning indicates that the stock's longer-term trend remains intact, although the immediate price action suggests caution among investors.
Market participants will be closely watching subsequent sessions to gauge whether the stock can stabilise above these technical benchmarks or if further downside pressure will emerge.
Company and Industry Overview
Venus Remedies operates within the Pharmaceuticals & Biotechnology industry, a sector characterised by innovation, regulatory scrutiny, and evolving market dynamics. The company's micro-cap status with a market capitalisation of ₹1,003 crore places it among smaller listed entities, which can be more susceptible to volatility and liquidity constraints.
Sectoral performance and broader market trends often influence the stock's movement, but company-specific news and fundamentals remain critical drivers of investor sentiment.
Want to dive deeper on Venus Remedies ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Market Implications
The lower circuit event for Venus Remedies highlights the volatility that can affect micro-cap stocks in the Pharmaceuticals & Biotechnology sector. While the stock remains near its 52-week high and above key moving averages, the immediate pressure reflects a cautious stance among investors.
Market participants should monitor trading volumes and price action in the coming days to assess whether the selling pressure subsides or if further declines are likely. The reduction in delivery volumes signals a potential shift in investor commitment, which could influence the stock's trajectory.
Given the sector's inherent complexities and the company's market position, a balanced approach that considers both technical signals and fundamental factors is advisable for investors evaluating Venus Remedies.
Summary
Venus Remedies' stock performance on 4 December 2025 was marked by a significant decline culminating in a lower circuit hit. Heavy selling pressure, reduced investor participation, and unfilled supply characterised the trading session. Despite this, the stock's proximity to its 52-week high and its standing above multiple moving averages suggest underlying resilience. Investors should remain vigilant to evolving market conditions and sector developments as they assess the stock's near-term prospects.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
